Back to Search
Start Over
Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
- Source :
-
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2023 Dec; Vol. 26 (4), pp. 812. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 1476-5608
- Volume :
- 26
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Prostate cancer and prostatic diseases
- Accession number :
- 37253975
- Full Text :
- https://doi.org/10.1038/s41391-023-00682-2